Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients-Reference-Cited by-同舟云学术

Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients

Published:2017-03-07 Issue:1 Volume:18 Page:
ISSN:1471-2172
Container-title:BMC Immunology
language:en
Short-container-title:BMC Immunol

Author:

Banas Bernhard,Böger Carsten A.,Lückhoff Gerhard,Krüger Bernd,Barabas Sascha,Batzilla Julia,Schemmerer Mathias,Köstler Josef,Bendfeldt Hanna,Rascle Anne,Wagner Ralf,Deml Ludwig,Leicht Joachim,Krämer Bernhard K.

Funder

Bayerische Forschungsstiftung (DE)

Universität Regensburg

Bayerische Forschungsstiftung

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1186/s12865-017-0194-z.pdf

Reference82 articles.

1. Hanley PJ, Bollard CM. Controlling cytomegalovirus: helping the immune system take the lead. Viruses. 2014;6:2242–58.

2. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009;22:76–98.

3. Schleiss MR. Cytomegalovirus in the neonate: immune correlates of infection and protection. Clin Dev Immunol. 2013;2013:501801.

4. Rossini G, Cerboni C, Santoni A, Landini MP, Landolfo S, Gatti D, et al. Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. Mediators Inflamm. 2012;2012:607276.

5. Jeitziner SM, Walton SM, Torti N, Oxenius A. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection. Eur J Immunol. 2013;43:2886–95.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients;Cells;2024-04-24

2. Discordance in serology for cytomegalovirus, Epstein‐Barr virus and toxoplasma among thoracic organ donors;Clinical Transplantation;2024-03-31

3. Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial;Clinical Infectious Diseases;2023-09-22

4. Interferon-gamma FlowSpot assay for the measurement of the T-cell response to cytomegalovirus;Heliyon;2023-06

5. IFN-γ-Based ELISpot as a New Tool to Detect Human Infections with Borna Disease Virus 1 (BoDV-1): A Pilot Study;Viruses;2023-01-10